Insider Transactions Reported by 18 Insiders of Rein Therapeutics, Inc.

Symbol
RNTX on Nasdaq
Location
Austin, TX

Insiders trading volume in the past year

Rein Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10%+ Owner $5,676,284 14 Jun 2024
Voss Capital, LP 10%+ Owner $1,909,612 +$551,059 +41% 14 Nov 2025
James Brian Windsor President and CEO $16,387 05 Dec 2024
Charles T. Garner Senior Vice President, Finance 25 Mar 2024
Timothy M. Cunningham Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney 16 May 2024
Rick Wanstall Chief Financial Officer and Treasurer 30 Mar 2022
Nolan Howard Sigal Director 15 Jun 2022
Vojo Vukovic Chief Medical Officer 30 Mar 2022
David Allen Annis SVP, Research 30 Mar 2022
William T. McKee Director 15 Jun 2022
Susan L. Drexler Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney 15 Jun 2022
Jeffrey A. Bailey Director 15 Jun 2021
Jodie Pope Morrison Director 15 Jun 2022
Reinhard J. Ambros Director 23 Jul 2025
William Fairey Director 23 Jul 2025
Manuel Aivado Director 23 Jul 2025
Josef H. von Rickenbach Director 23 Jul 2025
Alan A. Musso Director 23 Jul 2025

Recent Insider Transactions by Companies or Individuals for Rein Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Voss Capital, LP RNTX Common Stock, $0.001 par value Purchase 12.7% $127,593 $1.22 104,183 926,441 14 Nov 2025 By: Voss Value Master Fund, L.P.
Voss Capital, LP RNTX Common Stock, $0.001 par value Purchase 55.5% $247,965 $1.39 178,392 500,000 28 Oct 2025 By: Voss Value-Oriented Special Situations Fund, L.P.
Voss Capital, LP RNTX Common Stock, $0.001 par value Purchase 1.53% $6,625 $1.37 4,840 321,608 27 Oct 2025 By: Voss Value-Oriented Special Situations Fund, L.P.
Voss Capital, LP RNTX Common Stock, $0.001 par value Purchase 12.7% $126,920 $1.37 92,642 822,258 27 Oct 2025 By: Voss Value Master Fund, L.P.
Voss Capital, LP RNTX Common Stock, $0.001 par value Purchase 4.31% $41,957 $1.39 30,176 729,616 24 Oct 2025 By: Voss Value Master Fund, L.P.
Manuel Aivado RNTX Stock Option (right to buy) Award 17,500 17,500 23 Jul 2025 Direct
Josef H. von Rickenbach RNTX Stock Option (right to buy) Award 17,500 17,500 23 Jul 2025 Direct
Alan A. Musso RNTX Stock Option (right to buy) Award 17,500 17,500 23 Jul 2025 Direct
William C. Fairey RNTX Stock Option (right to buy) Award 17,500 17,500 23 Jul 2025 Direct
Reinhard J. Ambros RNTX Stock Option (right to buy) Award 17,500 17,500 23 Jul 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.